dc.contributor.author | Harrison, RJ | |
dc.contributor.author | Reszka, AP | |
dc.contributor.author | Haider, SM | |
dc.contributor.author | Romagnoli, B | |
dc.contributor.author | Morrell, J | |
dc.contributor.author | Read, MA | |
dc.contributor.author | Gowan, SM | |
dc.contributor.author | Incles, CM | |
dc.contributor.author | Kelland, LR | |
dc.contributor.author | Neidle, S | |
dc.date.accessioned | 2018-09-10T14:11:17Z | |
dc.date.issued | 2004 | |
dc.identifier | 23 | |
dc.identifier.citation | Bioorganic & Medicinal Chemistry Letters, 2004, 14 pp. 5845 - 5849 | |
dc.identifier.issn | 0960-894X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2609 | |
dc.identifier.doi | 10.1016/j.bmcl.2004.09.037 | |
dc.description.abstract | The synthesis and evaluation of a group of 2,6-, 2,7- and 3,6-bis-aminoalkylamido acridones are reported, which show a similar level of activity against telomerase in vitro compared to their acridine counterparts. Computer modelling and calculations of relative binding energies suggest an equivalent binding mode to human intramolecular G-quadruplex DNA, but with significantly reduced affinity, as a result of the limited delocalisation of the acridone chromophore compared to the acridine system. Thermal melting studies on acridone and acridine quadruplex complexes using a FRET approach support these predictions. Long-term cell proliferation studies at sub-cytotoxic doses with two representative acridones using the SKOV3 cell line, show that neither compound produces growth arrest, in contrast with the effects produced by the tri-substituted acridine compound BRACO-19. It is concluded that telomerase inhibitory activity is a necessary though by itself insufficient property in order for cellular growth arrest to occur at sub-toxic concentrations, and that tight quadruplex binding is also required. | |
dc.format.extent | 5845 - 5849 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.title | Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1016/j.bmcl.2004.09.037 | |
rioxxterms.licenseref.startdate | 2004 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Bioorganic & Medicinal Chemistry Letters | |
pubs.notes | keywords: Acridone, Telomerase, Quadruplex DNA | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Pharmacology & Stress Response (CPSR) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Pharmacology & Stress Response (CPSR) | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Pharmacology & Stress Response (CPSR) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Cancer Pharmacology & Stress Response (CPSR) | |
pubs.volume | 14 | en_US |
pubs.embargo.terms | Not known | |
icr.researchteam | Cancer Pharmacology & Stress Response (CPSR) | en_US |
dc.contributor.icrauthor | Gowan, Sharon | en |